Correction: SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May–June, 2021
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2458
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction: SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May–June, 2021 ; volume:23 ; number:1 ; day:27 ; month:1 ; year:2023 ; pages:1 ; date:12.2023
BMC public health ; 23, Heft 1 (27.1.2023), 1, 12.2023
- Urheber
-
Konu, Yao Rodion
Condé, Siaka
Gbeasor-Komlanvi, Fifonsi
Sadio, Arnold Junior
Tchankoni, Martin Kouame
Anani, Joel
Bitty-Anderson, Alexandra
Mirindi, Bisimwa Ruhana
Diallo, Fatoumata Binta Tidiane
MIjiyawa, Moustapha
Dagnra, Anoumou Claver
Ekouevi, Didier Koumavi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12889-023-15004-3
- URN
-
urn:nbn:de:101:1-2023040321390718014924
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Konu, Yao Rodion
- Condé, Siaka
- Gbeasor-Komlanvi, Fifonsi
- Sadio, Arnold Junior
- Tchankoni, Martin Kouame
- Anani, Joel
- Bitty-Anderson, Alexandra
- Mirindi, Bisimwa Ruhana
- Diallo, Fatoumata Binta Tidiane
- MIjiyawa, Moustapha
- Dagnra, Anoumou Claver
- Ekouevi, Didier Koumavi
- SpringerLink (Online service)
Ähnliche Objekte (12)
SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May–June, 2021
SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort
High SARS-CoV-2 seroprevalence among street adolescents in Lomé, Togo, 2021
SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey
Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection
Antibody seroprevalence and rate of asymptomatic infections with SARS-CoV-2 in Austrian hospital personnel
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
Seroprevalence of SARS-CoV-2 antibodies in low-income university students
Seroprevalence of SARS-CoV-2 antibodies in radio and television workers
SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May–June, 2021
SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort
High SARS-CoV-2 seroprevalence among street adolescents in Lomé, Togo, 2021
SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey
Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection
Antibody seroprevalence and rate of asymptomatic infections with SARS-CoV-2 in Austrian hospital personnel
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
Seroprevalence of SARS-CoV-2 antibodies in low-income university students
Seroprevalence of SARS-CoV-2 antibodies in radio and television workers
SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May–June, 2021
SARS-CoV-2 antibody seroprevalence in a large neuroimmunological patient cohort
High SARS-CoV-2 seroprevalence among street adolescents in Lomé, Togo, 2021
SARS-CoV-2 antibody seroprevalence in Lebanon: findings from the first nationwide serosurvey
Longitudinal SARS‐CoV‐2 seroprevalence in Portugal and antibody maintenance 12 months after infection
Antibody seroprevalence and rate of asymptomatic infections with SARS-CoV-2 in Austrian hospital personnel
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
Cross-sectional seroprevalence surveys of SARS-CoV-2 antibodies in children in Germany, June 2020 to May 2021
Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China
Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
Seroprevalence of SARS-CoV-2 antibodies in low-income university students